Covalon Technologies Gross Margin 2013-2024 | CVALF

Covalon Technologies gross margin from 2013 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Covalon Technologies Gross Margin 2013-2024 | CVALF

Covalon Technologies gross margin from 2013 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$234.6B
Intuitive Surgical (ISRG)$174.6B
Alcon (ALC)$48.6B
IQVIA Holdings (IQV)$43.6B
IDEXX Laboratories (IDXX)$42.1B
Edwards Lifesciences (EW)$41.8B
DexCom (DXCM)$28.1B
STERIS (STE)$24B
SONOVA HOLDING (SONVY)$21.5B
Waters (WAT)$19.5B
Hologic (HOLX)$19.2B
Sysmex ADR (SSMXY)$12.3B
Fresenius Medical Care AG KGaA (FMS)$12.3B
Teleflex (TFX)$11.6B
Globus Medical (GMED)$9.5B
Penumbra (PEN)$7.3B
Glaukos (GKOS)$6.8B
Masimo (MASI)$6.1B
TransMedics (TMDX)$5B
Integer Holdings (ITGR)$4.3B
PROCEPT BioRobotics (PRCT)$4.3B
Tandem Diabetes Care (TNDM)$2.8B
Inari Medical (NARI)$2.7B
LivaNova (LIVN)$2.6B
Nihon Kohden (NHNKY)$2.6B
Veracyte (VCYT)$2.6B
Elekta AB (EKTAY)$2.4B
RxSight (RXST)$2.1B
Integra LifeSciences Holdings (IART)$1.3B
Pulse Biosciences (PLSE)$1.2B